Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RNAAtrium Therapeutics, Inc.

Nasdaq · CIK 0002093101
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts110

Identity from submissions API

NameAtrium Therapeutics, Inc.
CIK0002093101
TickersRNA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN394639499
LEI—
Fiscal year end1231
State of incorporation—
Phone6198760700
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO
CA
CA
Mailing address
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

61 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000732 005-95606 261556471 34 7775
2026-11-12 10-Q 10-Q 0001193125-26-458471 001-43008 261547276 34 13590184 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458459 001-43008 261547198 34 252368 1 1
2026-11-02 8-K 8-K 7.01,8.01,9.01 0001193125-26-442601 001-43008 261509842 34 13397478 1 1
2026-10-27 8-K 8-K 8.01,9.01 0001193125-26-432949 001-43008 261487701 34 182835 1 1
2026-10-09 8-K/A 8-K/A 8.01 0001193125-26-418417 001-43008 261451106 34 146257 1 1
2026-10-08 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-417402 001-43008 261448278 34 685421 1 1
2026-09-22 4 4 0001193125-26-397971 4850
2026-09-22 4 4 0001193125-26-397967 4884
2026-09-22 4 4 0001193125-26-397955 4817
2026-09-22 4 4 0001193125-26-397951 4805
2026-09-22 4 4 0001193125-26-397948 4900
2026-09-22 4 4 0001193125-26-397944 4938
2026-09-22 4 4 0001193125-26-397941 4842
2026-09-22 4 4 0001193125-26-397936 4859
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000917 005-95606 261282879 34 12332
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003500 005-95606 261281444 34 14130
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000590 005-95606 261277451 34 7723
2026-08-13 10-Q 10-Q 0001193125-26-349488 001-43008 261274563 34 7665862 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349482 001-43008 261274543 34 241495 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002192 005-95606 261206031 34 10966
2026-07-14 8-K 8-K 8.01,9.01 0001193125-26-303393 001-43008 261175022 34 164592 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000145 005-95606 26988626 34 18393
2026-05-14 10-Q 10-Q 0001193125-26-224243 001-43008 26980021 34 5906905 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-224238 001-43008 26979999 34 225728 1 1
2026-04-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001673 005-95606 26901038 34 10907
2026-04-22 4 4 0001193125-26-170964 7611
2026-04-22 4 4 0001193125-26-170963 7596
2026-04-22 4 4 0001193125-26-170960 7553
2026-04-22 4 4 0001193125-26-170914 7652
2026-04-22 4 4 0001193125-26-170907 7570
2026-04-22 4 4 0001193125-26-170906 7561
2026-04-17 S-8 S-8 0001193125-26-161513 333-295136 26871530 33 372367 1 1
2026-04-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000316 005-95606 26847843 34 7557
2026-03-02 4 4 0001193125-26-085922 5388
2026-03-02 4 4 0001193125-26-085921 5392
2026-03-02 4 4 0001193125-26-085920 5390
2026-03-02 4 4 0001193125-26-085919 5402
2026-03-02 4 4 0001193125-26-085918 5398
2026-02-27 8-K 8-K 1.01,5.01,5.02,9.01 0001193125-26-083227 001-43008 26701936 34 909934 1 1
2026-02-26 3 3 0001193125-26-077934 20033
2026-02-26 3 3 0001193125-26-077907 19423
2026-02-26 3 3 0001193125-26-077801 19141
2026-02-26 3 3 0001193125-26-077764 18498
2026-02-26 3 3 0001193125-26-077763 19102
2026-02-26 3 3 0001193125-26-077740 18624
2026-02-26 3 3 0001193125-26-077739 19918
2026-02-26 3 3 0001193125-26-077733 18902
2026-02-26 3 3 0001193125-26-077728 19120
2026-02-26 3 3 0001193125-26-077718 19186
2026-02-26 3 3 0001193125-26-077716 19172
2026-02-26 8-K 8-K 7.01,9.01 0001193125-26-077105 001-43008 26690044 34 3302432 1 1
2026-02-26 S-8 S-8 0001193125-26-075072 333-293782 26684452 33 519203 1 1
2026-02-26 SEC STAFF ACTION filename1.pdf 9999999997-26-000345 4161
2026-02-26 CERT RNA_Form10_Cert_2093101.pdf 0001354457-26-000219 001-43008 26682764 34 591686
2026-02-24 CORRESP filename1.htm 0001193125-26-066190 10680
2026-02-17 10-12B/A 10-12B/A 0001193125-26-055010 001-43008 26643241 34 6596871
2026-01-30 10-12B/A 10-12B/A 0001193125-26-029976 001-43008 26580239 34 5658203
2026-01-29 CORRESP filename1.htm 0001193125-26-029980 25114
2026-01-27 UPLOAD filename1.pdf 0000000000-26-000898 001-43008 50241
2025-12-10 10-12B 10-12B 0001193125-25-314415 001-43008 251562773 34 3280709

Latest XBRL company facts

One latest value per concept from companyfacts (110 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 21.57M 2026-11-02 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
ffd NetFeeAmt NetFeeAmt USD 607.92 2026-04-16 S-8 2026-04-17 0001193125-26-161513
ffd TtlFeeAmt TtlFeeAmt USD 607.92 2026-04-16 S-8 2026-04-17 0001193125-26-161513
ffd TtlOfferingAmt TtlOfferingAmt USD 4.40M 2026-04-16 S-8 2026-04-17 0001193125-26-161513
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-16 S-8 2026-04-17 0001193125-26-161513
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 782,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 625,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -347,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 217.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 6.30M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.13M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap Assets Assets USD 263.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AssetsCurrent Assets, Current USD 258.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 230.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap Cash Cash USD 270.00M 2026-02-26 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 44.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 44.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 44.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 16.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 16.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap CommonStockValue Common Stock, Value, Issued USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -41.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 42.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 9.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 32.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 321,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestWriteoff Debt Securities, Available-for-Sale, Accrued Interest Writeoff USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349488
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss USD 187.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 187.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 187.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 187.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap Depreciation Depreciation USD 846,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349488
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 38.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -41.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -3.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -275,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -7.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 819,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 807,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 7.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap InterestIncomeOther Interest Income, Other USD 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap Liabilities Liabilities USD 58.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 263.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap LiabilitiesCurrent Liabilities, Current USD 24.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 1 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 295.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -189.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -60.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -41.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 103,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OperatingExpenses Operating Expenses USD 84.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -46.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 679,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 520,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -347,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -112,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 499,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 6.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 230.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 40.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 301.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 43.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -41.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 45.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 312,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 106,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -12.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 37.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 0 2026-02-26 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-224243
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 704,520 2026-09-18 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap ShortTermInvestments Short-term Investments USD 187.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 205.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 17.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 17.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458471

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →